04 Oct, EOD - Indian

SENSEX 81688.45 (-0.98)

Nifty 50 25014.6 (-0.93)

Nifty Bank 51462.05 (-0.74)

Nifty IT 41912.5 (0.36)

Nifty Midcap 100 58474.45 (-0.93)

Nifty Next 50 74620.25 (-1.10)

Nifty Pharma 23094.7 (-0.36)

Nifty Smallcap 100 18758.65 (-1.02)

04 Oct, EOD - Global

NIKKEI 225 38635.62 (0.22)

HANG SENG 22736.87 (2.82)

S&P 5807.5 (0.80)

Login/Signup
LOGIN HERE
Cancel

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
06-Aug-2024 12-Aug-2024 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Unaudited financial results for the quarter ended 30.06.2024 and any other business with the permission of the Chair.
11-May-2024 28-May-2024 Accounts Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve AUDITED FINANCIAL RESULTS The Board Meeting to be held on 25/05/2024 has been revised to 28/05/2024 The Board Meeting to be held on 25/05/2024 has been revised to 28/05/2024 (As Per BSE Announcement Dated on 21/05/2024) Audited Results for the Quarter ended 31.03.2024 (As Per BSE Announcement Dated on 28.05.2024)
23-Jan-2024 31-Jan-2024 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the Unaudited financial results for the quarter ended 31.12.2023. Results for the quarter ended 31.12.2023 (As Per BSE Announcement dated on 31.01.2024)
06-Nov-2023 14-Nov-2023 Quarterly Results Quarterly Results Unaudited financial results for the quarter ended 30.09.2023 Outcome of Board Meeting held on 14.11.2023 (As per BSE Announcement Dated on 14/11/2023)
29-Sep-2023 29-Sep-2023 Change in Auditors Outcome of Board Meeting held on 29.09.2023
02-Sep-2023 02-Sep-2023 AGM Outcome of Board Meeting held on 02.09.2023 Change in Management Appointment of Statutory Auditor (As Per BSE Announcement Dated on 04/09/2023)
04-Aug-2023 14-Aug-2023 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 30.06.2023 Unaudited financial results for the quarter ended 30.06.2023 Unaudited financial results for the quarter ended 30.06.2023 (As Per BSE Announcement Dated on 14.08.2023)
19-May-2023 29-May-2023 Accounts Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2023 Audited Financial Results for the quarter and year ended 31.03.2023 (As Per BSE Announcement Dated on 29.05.2023)
23-Jan-2023 31-Jan-2023 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 31.12.2022. Approval of un-audited financial results for the quarter ended 31.12.2022. (As Per BSE Announcement Dated on 31.01.2023)
21-Oct-2022 28-Oct-2022 Quarterly Results Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve Intimation of Board meeting to be held on 28.10.2022 For the unaudited financial results for the quarter ended 30.09.2022 For the unaudited financial results for the quarter ended 30.09.2022 (As Per BSE Announcement Dated on 28.10.2022)
02-Aug-2022 10-Aug-2022 Quarterly Results Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve 1. Unaudited financial results for the quarter ended 30.06.2022. 2. To consider the decision of change of name of the company. 3. Any other business with the permission of the Chair. Unaudited financial results for the quarter ended 30.06.2022 Outcome of Board Meeting (As Per BSE Announcement dated on 10.08.2022)
11-May-2022 19-May-2022 Accounts Audited Results & Quarterly Results Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve audited financial results for the quarter and year ended 31.03.2022 Audited Financial Results for the Quarter and Year ended 31.03.2022 (As per BSE Announcement Dated on 19/5/2022)
19-Jan-2022 27-Jan-2022 Quarterly Results Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 inter alia to consider and approve Board meeting intimation for unaudited financial results for the quarter ended 31.12.2021 Un-audited financial results for the quarter ended 31.12.2021 (As Per BSE Announcement Dated on 27.01.2022)
03-Nov-2021 12-Nov-2021 Quarterly Results Quarterly Results Outcome of Board Meeting held on 12.11.2021 (As per BSE Announcement Dated on 12/11/2021)
03-Aug-2021 11-Aug-2021 Quarterly Results Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.06.2021 Unaudited financial results for the quarter ended 30.06.2021 Dr Habeebullah Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2021. (As Per BSE Announcement Dated on 11.08.2021)
1 2